WALTHAM, MA — July 22, 2020 — Thermo Fisher Scientific announces the launch of an industry-leading product, compliance, and services portfolio, compatible with current Good Manufacturing Practice (cGMP) and designed to enable rapid start-up of clinical and commercial cell and gene therapy manufacturing.